Protective effect of Nigella sativa oil against binge ethanol-induced oxidative stress and liver injury in rats

2014 ◽  
Vol 12 (7) ◽  
pp. 495-499 ◽  
Author(s):  
Seval Develi ◽  
Betül Evran ◽  
Esra Betül Kalaz ◽  
Necla Koçak-Toker ◽  
Gül Özdemirler Erata
Author(s):  
Kevser Tanbek ◽  
Elif Ozerol ◽  
Sedat Bilgic ◽  
Mustafa Iraz ◽  
Nurhan Sahin ◽  
...  

Antioxidants ◽  
2020 ◽  
Vol 9 (10) ◽  
pp. 965
Author(s):  
Mohammad Abdullah-Al-Shoeb ◽  
Kenta Sasaki ◽  
Saori Kikutani ◽  
Nanami Namba ◽  
Keiichi Ueno ◽  
...  

An overdose of acetaminophen (APAP), the most common cause of acute liver injury, induces oxidative stress that subsequently causes mitochondrial impairment and hepatic necroptosis. N-acetyl-L-cysteine (NAC), the only recognized drug against APAP hepatotoxicity, is less effective the later it is administered. This study evaluated the protective effect of mitochondria-specific Mito-TEMPO (Mito-T) on APAP-induced acute liver injury in C57BL/6J male mice, and a three dimensional (3D)-cell culture model containing the human hepatoblastoma cell line HepG2. The administration of Mito-T (20 mg/kg, i.p.) 1 h after APAP (400 mg/kg, i.p.) injection markedly attenuated the APAP-induced elevated serum transaminase activity and hepatic necrosis. However, Mito-T treatment did not affect key factors in the development of APAP liver injury including the activation of c-jun N-terminal kinases (JNK), and expression of the transcription factor C/EBP homologous protein (CHOP) in the liver. However, Mito-T significantly reduced the APAP-induced increase in the hepatic oxidative stress marker, nitrotyrosine, and DNA fragmentation. Mito-T markedly attenuated cytotoxicity induced by APAP in the HepG2 3D-cell culture model. Moreover, liver regeneration after APAP hepatotoxicity was not affected by Mito-T, demonstrated by no changes in proliferating cell nuclear antigen formation. Therefore, Mito-T was hepatoprotective at the late-stage of APAP overdose in mice.


2017 ◽  
Vol 85 ◽  
pp. 7-15 ◽  
Author(s):  
Zeba Farooqui ◽  
Faizan Ahmed ◽  
Sana Rizwan ◽  
Faaiza Shahid ◽  
Aijaz Ahmed Khan ◽  
...  

2020 ◽  
Vol 253 ◽  
pp. 112653 ◽  
Author(s):  
Amin Mokhtari-Zaer ◽  
Fatemeh Norouzi ◽  
Vahid Reza Askari ◽  
Mohammad Reza Khazdair ◽  
Nama Mohammadian Roshan ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Yan Wang ◽  
Zhenzhen Zhang ◽  
Xia Wang ◽  
Dan Qi ◽  
Aijuan Qu ◽  
...  

Alcoholic liver disease (ALD) is a leading cause of liver-related morbidity and mortality worldwide. There is no effective treatment to prevent the disease progression. Magnesium isoglycyrrhizinate (MgIG) showed potent anti-inflammatory, antioxidant, and hepatoprotective activities and was used for treating liver diseases in Asia. In this study, we examined whether MgIG could protect mice against alcohol-induced liver injury. The newly developed chronic plus binge ethanol feeding model was used to study the role of MgIG in ALD. Serum liver enzyme levels, H&E staining, immunohistochemical staining, flow cytometric analysis, and real-time PCR were used to evaluate the liver injury and inflammation. We showed that MgIG markedly ameliorated chronic plus binge ethanol feeding liver injury, as shown by decreased serum alanine transaminase and aspartate aminotransferase levels and reduced neutrophil infiltration. The reason may be attributed to the reduced expression of proinflammatory cytokines and chemokines with the treatment of MgIG. The hepatoprotective effect of MgIG was associated with suppression of neutrophil ROS production as well as hepatocellular oxidative stress. MgIG may play a critical role in protecting against chronic plus binge ethanol feeding-induced liver injury by regulating neutrophil activity and hepatic oxidative stress.


Sign in / Sign up

Export Citation Format

Share Document